SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-026161
Filing Date
2021-11-10
Accepted
2021-11-10 16:17:09
Documents
65
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vtgn20210930_10q.htm   iXBRL 10-Q 1892329
2 EXHIBIT 10.1 ex_296584.htm EX-10.1 37846
3 EXHIBIT 31.1 ex_300833.htm EX-31.1 8829
4 EXHIBIT 31.2 ex_300834.htm EX-31.2 8737
5 EXHIBIT 32.1 ex_300835.htm EX-32.1 4687
  Complete submission text file 0001437749-21-026161.txt   7279634

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vtgn-20210930.xsd EX-101.SCH 61956
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtgn-20210930_cal.xml EX-101.CAL 38205
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtgn-20210930_def.xml EX-101.DEF 463559
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtgn-20210930_lab.xml EX-101.LAB 349277
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtgn-20210930_pre.xml EX-101.PRE 482131
11 EXTRACTED XBRL INSTANCE DOCUMENT vtgn20210930_10q_htm.xml XML 1029955
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37761 | Film No.: 211396871
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences